The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of weight gain and overall survival of patients with advanced non–small cell lung cancer (NSCLC) treated with first-line platinum-based chemotherapy.
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; Asahi Kasei; Astellas Pharma; BASF; Helsinn Therapeutics; HERON; Napo Pharmaceuticals; Oragenics; Oragenics; Pfizer/EMD Serono; Vector Oncology
Expert Testimony - Regents of the University of California
 
Florian J. Fintelmann
Patents, Royalties, Other Intellectual Property - Mass General Brigham
 
Fiona Hilton
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Lisa Tarasenko
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Roberto A Calle
Employment - Pfizer; Regeneron
Stock and Other Ownership Interests - Pfizer; Regeneron
 
Philip D. Bonomi
Honoraria - Helsinn Therapeutics; Merck; pfizer
Consulting or Advisory Role - Helsinn Therapeutics; Merck; Pfizer
Research Funding - Helsinn Healthcare (Inst); Pfizer (Inst)